Tumour Markers

  • You've just added this product to the cart:

    Access 2 Immunoassay System

    Access 2
    Access 2

    Access 2 Immunoassay System

    Exceptional productivity in a compact design

    Maximize your laboratory’s productivity with the Access 2 Immunoassay System, a powerful and reliable benchtop immunoassay analyzer featuring a space-saving design, user-friendly features and a complete menu of more than 50 tests. Using feedback from customers, we’ve enhanced the Access 2 with new features to improve your experience. Now you can increase system availability by providing remote instrument diagnostics through desktop sharing, identify reagent packs automatically using an internal barcode reader to minimize operator loading errors, and make analyzer operation more comfortable with an ergonomic workstation design.

  • You've just added this product to the cart:

    BCR-ABL P190 ELITe MGB Kit

    BCR-ABL P190 ELITe MGB Kit

    The product of the Philadelphia translocation, the BCR/ABL oncogene P190 isoform, is commonly found in acute lymphoid leukemia, a rare disease that can be fatal within a matter of months if untreated. Detection and quantification of P190 BCR-ABL fusion gene, by molecular methods, is crucial for patient management, to initiate the appropriate treatment and measure response to therapy.

  • You've just added this product to the cart:

    BCR-ABL P210 ELITe MGB Kit

    BCR-ABL P210 ELITe MGB Kit

    The product of the Philadelphia translocation, the BCR/ABL oncogene P210 isoform, is typically found in chronic myelogenous leukemia, and in acute lymphoid and myeloid leukemia, causing the cells to divide uncontrollably and inducing severe outcomes among patients. Detection and quantification of P210 BCR-ABL fusion gene, by molecular methods, is crucial for patient management, to initiate the appropriate treatment, measure the response to therapy and predict relapse

  • You've just added this product to the cart:

    Biochip

    Placeholder

    Biochip

    Tumour markers are proteins found in the blood, tissue or urine that may be directly produced by a tumour or by other tissues in response to the presence of a tumour.

    Prostate cancer is the second most common cause of cancer in men. If it is detected early enough, it has a 90% cure rate. Carcinoembryonic Antigen (CEA), a non-specific cancer antigen produced in response to malignant cells, is measured in addition to total and free Prostate Specific Antigen (PSA). Therefore, testing for CEA simultaneously with PSA provides a more accurate diagnosis of prostate cancer. Randox Tumour PSA Array enables the simultaneous determination of these antigens in a single sample.

  • You've just added this product to the cart:

    BIONEXIA BTA

    BIONEXIA BTA

    Non-invasive screening and monitoring of bladder cancer

    The BIONEXIA® BTA rapid test is a useful aid for screening of high-risk populations and monitoring of bladder cancer using urine specimens.

    • Easy test procedure and interpretation
    • No patient discomfort
    • All-inclusive kit
  • You've just added this product to the cart:

    Elisa

    elisa tumor markers
    elisa tumor markers

    Elisa

    Tumor markers are integral part of modern cancer management. They are primarily used for monitoring but also for diagnostic and prognostic purposes in combination with clinical and other paraclinical parameters.

  • You've just added this product to the cart:

    Prostate Health Index

    Placeholder

    Prostate Health Index

    WHAT IS phi ?

    The prostate health index (phi) is a mathematical formula that provides a probability of prostate cancer (PCa) by combining three tests (prostate-specific antigen [PSA], free PSA, and p2PSA) into a single score. Calculated by using an algorithm in the Beckman Coulter Access instrument, the phi score can provide more accurate information about the meaning of an elevated PSA level and the probability of finding prostate cancer on a biopsy.

    Details

  • You've just added this product to the cart:

    VIDAS Tumour Markers

    VIDAS Tumour Markers

    Diagnosis, prognosis or treatment monitoring of various cancers

    The VIDAS® panel of Tumour Markers offers a rapid, automated and reliable solution to meet clinicians’ main needs.

    • Excellent precision: within-run and between-run reproducibility < 5% for each test
    • Reliable results even at low concentrations
    • Flexible and cost-effective solution